Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home

Weight Management Protocol

CagrilintideComplete Dosing & Administration Guide

Long-acting amylin analog that supercharges satiety signals, delivering powerful appetite suppression and up to 10-15% weight loss with convenient once-weekly dosing.

Dose Range

0.3-4.5mg

Frequency

Once weekly

Route

Subcutaneous injection

Cycle Length

Ongoing/indefinite

Dosing

How much
do I take?

Starting Dose

0.3-0.6 mg

Frequency

Once weekly

Duration

2-4 weeks

Start low to let your body adjust to the new satiety signals. Most people tolerate cagrilintide well, but starting slow helps minimize any GI discomfort.

Standard Dose

1.2-2.4 mg

Frequency

Once weekly

Duration

Ongoing

The sweet spot for most people. This dose range provides meaningful appetite suppression and steady weight loss without overwhelming side effects.

Advanced Dose

4.5 mg

Frequency

Once weekly

Duration

Ongoing

Maximum studied dose for those who tolerate lower doses well and want maximum effect. Often used in combination with semaglutide for enhanced results.

Timing

Best time to take

Same day each week, any time of day that works for your schedule

With food?

Can be taken with or without food - choose whatever is most convenient

If stacking

When combining with semaglutide (CagriSema), both can be injected on the same day. The combination is designed to be taken together for synergistic effects.

Adjusting Your Dose

Increase if

  • +You have tolerated the current dose well for at least 4 weeks
  • +Weight loss has slowed or plateaued
  • +Appetite suppression effects have diminished
  • +You want enhanced results and can handle potential increased side effects

Decrease if

  • -Experiencing persistent nausea that affects quality of life
  • -GI side effects are severe or not improving after 2 weeks
  • -Rapid weight loss exceeding 2-3 lbs per week
  • -Feeling excessively full or unable to eat adequate nutrition

Signs of right dose

  • Gradual, steady weight loss of 1-2 lbs per week
  • Noticeably reduced appetite without severe nausea
  • Feeling satisfied with smaller portions
  • Manageable or no side effects

Dosing Calculator

Calculate Your Exact Dose

1
2
3
4

Step 1: Peptide Weight

Find the weight printed on your peptide vial label

Look here!

The weight is on the label

Peptide vial
5mg

Select Weight

mg

Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)

Administration

How do I
use it?

Reconstitution

What you need

  • Bacteriostatic water (BAC water)
  • Insulin syringe (29-31 gauge, 0.5-1mL)
  • Alcohol swabs
  • Sterile vial of cagrilintide powder
  • Sharps container for safe needle disposal

Example

5mg vial + 1mL BAC water = 5mg/mL concentration. Each 0.1mL (10 units) contains 0.5mg cagrilintide.

For 2.4mg dose at 5mg/mL concentration: draw 0.48mL (48 units on insulin syringe). For easier math, many use 2mL water with 5mg vial for 2.5mg/mL.

Injection

Route

Subcutaneous injection once weekly

Best sites

  • Abdomen (2 inches away from navel)
  • Front of thigh (middle third)
  • Upper arm (outer area)
  • Lower back area (above buttocks)

Technique

  • 1.Wash hands thoroughly and clean injection site with alcohol swab
  • 2.Let the alcohol dry completely - this reduces stinging
  • 3.Pinch the skin to create a fold for easier injection
  • 4.Insert needle at a 45-90 degree angle depending on body composition
  • 5.Inject the medication slowly over 5-10 seconds
  • 6.Hold for 10 seconds before removing needle, then release skin
Full Injection Guide

Storage

Before reconstitution

Store in refrigerator at 36-46 degrees F (2-8 degrees C). Keep in original packaging to protect from light. Never freeze. Can tolerate brief room temperature exposure during shipping but return to refrigeration promptly.

After reconstitution

Refrigerate immediately after mixing with bacteriostatic water. Do not freeze reconstituted solution. Use within 28 days of first puncture. Keep vial upright to minimize contamination risk.

Signs of degradation

  • Cloudy or discolored solution (should be clear)
  • Visible particles, floaters, or clumps
  • Solution that has been accidentally frozen
  • Unusual smell when opening vial

Sample Daily Schedule

Weekly (choose a consistent day)

Current dose per titration schedule injection

Site: Rotate between abdomen, thigh, and arm

Set a recurring phone reminder for the same day and time each week. Many people choose weekend mornings.

If combining with semaglutide

Both can be injected same day injection

Site: Use different injection sites for each medication

The CagriSema combination uses 2.4mg of each. Inject at separate sites at least 2 inches apart.

Safety

Is it
safe?

Safety Profile

Cagrilintide has been studied in multiple Phase 2 and Phase 3 trials involving thousands of participants. The safety profile is generally favorable, with most side effects being GI-related (nausea, constipation, diarrhea) that improve with time and gradual dose escalation. Serious adverse events are rare, and the drug was well-tolerated even at the highest studied doses.

Phase 2 trials included over 700 participants with follow-up periods up to 26 weeks. Phase 3 REDEFINE trials enrolled over 3,400 participants with 68-week follow-up. The combination with semaglutide (CagriSema) showed similar tolerability to semaglutide alone.

Common Side Effects

Experienced by some users

Nausea

The most frequently reported side effect, affecting 20-47% of users depending on dose. Usually mild and improves over the first few weeks.

Management: Start with lower doses and titrate slowly. Eat smaller, more frequent meals. Avoid greasy or heavy foods.

Constipation

Occurs due to slowed gastric emptying and reduced food intake. Reported in 15-25% of users.

Management: Increase fiber and water intake. Stay physically active. Consider a stool softener if needed.

Diarrhea

May occur especially during dose adjustments. Usually temporary and mild to moderate.

Management: Stay well hydrated. Avoid foods that trigger symptoms. Usually resolves within 1-2 weeks.

Injection site reactions

Mild redness, swelling, or itching at injection sites. Generally resolves quickly.

Management: Rotate injection sites regularly. Ensure proper injection technique. Apply ice if needed.

Less Common

  • Vomiting
  • Headache

These typically resolve with continued use or dose adjustment.

Stop and Seek Help If

  • ×Severe allergic reaction (rash, swelling, difficulty breathing)
  • ×Persistent severe nausea or vomiting not improving with dose reduction
  • ×Signs of pancreatitis (severe abdominal pain radiating to back)
  • ×Planned pregnancy or positive pregnancy test
  • ×Inability to maintain adequate nutrition despite dose adjustments
  • ×Any concerning symptoms your healthcare provider advises stopping for

Always consult your healthcare provider before stopping or modifying your dose. Do not stop abruptly without medical guidance, especially if you are also on diabetes medications.

Interactions

With other peptides

  • Designed to be combined - the CagriSema combination shows enhanced weight loss through complementary mechanisms
  • May be combined, but both affect appetite strongly - monitor for excessive appetite suppression
  • Generally safe to combine for gut support during weight loss
  • !Do NOT combine - both are amylin analogs with overlapping mechanisms

With medications

  • !Insulin - Increases hypoglycemia risk - insulin dose may need reduction, especially post-meal doses
  • !Sulfonylureas - Increased hypoglycemia risk - may need dose adjustment with provider guidance
  • Metformin - Generally safe to combine - may provide complementary metabolic benefits
  • Oral medications - Slowed gastric emptying may affect absorption timing - take critical meds separately

With supplements

  • Protein supplements - Highly recommended to maintain muscle mass during weight loss
  • Fiber supplements - Can help with constipation - take with plenty of water
  • Multivitamins - Recommended as reduced food intake may limit nutrient intake
  • Electrolytes - Helpful if experiencing GI side effects to prevent dehydration

Want the Full Picture?

View the complete Cagrilintide research profile including mechanism of action, clinical studies, effectiveness timeline, and FAQ.

View Full Cagrilintide Profile

Medical Disclaimer

Cagrilintide is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or treatment protocol.

Last updated: 2/8/2026

Cagrilintide Protocol — Complete Dosing & Administration Guide | Peptide Initiative